Ligand Pharmaceuticals Incorporated Analysis
| Analyst Ratings |
|
Average Target Price
|
111.67
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.43
|
1.31
|
0.88
|
204.65%
|
|
2022-06-30
|
0.43
|
1.03
|
0.60
|
139.53%
|
|
2022-03-31
|
0.66
|
0.76
|
0.10
|
15.15%
|
|
2021-12-31
|
1.37
|
1.80
|
0.43
|
31.39%
|
|
2021-09-30
|
1.04
|
1.58
|
0.54
|
51.92%
|
|
2021-06-30
|
1.36
|
1.63
|
0.27
|
19.85%
|
|
2021-03-31
|
1.13
|
1.41
|
0.28
|
24.78%
|
|
2020-12-31
|
0.99
|
1.62
|
0.63
|
63.64%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
3.10
|
|
2021-12-31
|
6.42
|
|
2020-12-31
|
4.55
|
|
2019-12-31
|
3.04
|
|
2018-12-31
|
7.16
|
|
2017-12-31
|
3.24
|
|
2016-12-31
|
3.34
|
|
2015-12-31
|
3.36
|
|
2014-12-31
|
1.55
|
|
2013-12-31
|
0.63
|
|
2012-12-31
|
-0.05
|
|
2011-12-31
|
0.58
|
|
2010-12-31
|
-3.61
|
|
2009-12-31
|
-0.48
|
|
2008-12-31
|
-6.06
|
|
2007-12-31
|
16.75
|
|
2006-12-31
|
-4.71
|
|
2005-12-31
|
-3.90
|
|
2004-12-31
|
-1.74
|
|
2003-12-31
|
-2.70
|
|
2002-12-31
|
-2.58
|
|
2001-12-31
|
-3.60
|
|
2000-12-31
|
-6.37
|
|
1999-12-31
|
-9.54
|
|
1998-12-31
|
-10.74
|
|
1997-12-31
|
-6.48
|
|
1996-12-31
|
-7.74
|
|
1995-12-31
|
-6.78
|
|
1994-12-31
|
-7.74
|